"10.1371_journal.pone.0119755","plos one","2015-03-20T00:00:00Z","Theodoros Agorastos; Kimon Chatzistamatiou; Taxiarchis Katsamagkas; George Koliopoulos; Alexandros Daponte; Theocharis Constantinidis; Theodoros C Constantinidis; and the HERMES study group","4th Department of Obstetrics and Gynecology, Aristotle University of Thessaloniki, Hippokratio General Hospital, Thessaloniki, Greece; 3rd Department of Obstetrics and Gynecology, University of Athens, Attikon Hospital, Athens, Greece; Department of Obstetrics and Gynecology, University of Thessaly, General University Hospital, Larissa, Greece; Peripheral Laboratory of Public Health, Hellenic Center for Disease Control and Prevention, Ministry of Health, Alexandroupoli, Greece; Laboratory of Hygiene and Environmental Protection / Laboratory of Microbiology, Democritus University of Thrace, Alexandroupoli, Greece","Conceived and designed the experiments: TA. Performed the experiments: TA KC TK GK AD TC TCC. Analyzed the data: TA KC TK GK TCC. Contributed reagents/materials/analysis tools: TC TCC. Wrote the paper: TA KC GK.","The authors have read the journals policy and the authors of this manuscript have the following competing interests: KC and TK had their travel expenses and fees for two Congresses (EUROGIN 2012 and EUROGIN 2013) covered by Roche Diagnostics. GK, AD, TC and TCC have declared that no competing interests exist. TA has performed research trials partially supported by Vianex/Sanofi Pasteur MSD and has had travel expenses for conferences/meetings/symposia occasionally Cover Letter covered by either Vianex/Sanofi Pasteur MSD, GlaxoSmithKline and Roche Diagnostics. This does not alter the authorsâ€™ adherence to PLOS ONE policies on sharing data and materials. All the authors declare no competing interests related to the commercial funder, Roche Diagnostics, concerning employment, consultancy, patents, products in development, marketed products etc.","2015","03","Theodoros Agorastos","TA",8,FALSE,1,7,5,3,TRUE,TRUE,TRUE,1,"8",TRUE
